ES2185900T3 - Composicion farmacologica que comprende un componente p serico del amiloide para el tratamiento profilactico o terapeutico de infecciones viricas y un hit para la deteccion de union entre dicha composicion y componentes viricos. - Google Patents
Composicion farmacologica que comprende un componente p serico del amiloide para el tratamiento profilactico o terapeutico de infecciones viricas y un hit para la deteccion de union entre dicha composicion y componentes viricos.Info
- Publication number
- ES2185900T3 ES2185900T3 ES97900943T ES97900943T ES2185900T3 ES 2185900 T3 ES2185900 T3 ES 2185900T3 ES 97900943 T ES97900943 T ES 97900943T ES 97900943 T ES97900943 T ES 97900943T ES 2185900 T3 ES2185900 T3 ES 2185900T3
- Authority
- ES
- Spain
- Prior art keywords
- viric
- composition
- component
- profilactic
- amiloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN UN COMPONENTE AMILOIDE P DE LAS PROTEINAS SERICAS, CAPAZ DE FIJAR LOS VIRUS, ESPECIALMENTE LOS MIXOVIRUS, POR EJEMPLO, LOS VIRUS DE LA GRIPE, IMPIDIENDO DE ESE MODO LA TRANSMISION E INFECCION CON TALES VIRUS. SE PREFIERE LA ADMINISTRACION MUCOSA, POR EJEMPLO, SAP INCORPORADO A UNA PULVERIZACION NASAL O GOTAS NASALES. SE PROPORCIONA IGUALMENTE UN PROCEDIMIENTO PARA MEDIR LA FIJACION DEL SAP A LA HEMAGLUTININA DE LOS SUBTIPOS Y CEPAS MAS FRECUENTES DEL VIRUS DE LA GRIPE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK7996 | 1996-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2185900T3 true ES2185900T3 (es) | 2003-05-01 |
Family
ID=8089501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97900943T Expired - Lifetime ES2185900T3 (es) | 1996-01-25 | 1997-01-24 | Composicion farmacologica que comprende un componente p serico del amiloide para el tratamiento profilactico o terapeutico de infecciones viricas y un hit para la deteccion de union entre dicha composicion y componentes viricos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6406698B1 (es) |
EP (1) | EP0915707B1 (es) |
AT (1) | ATE226829T1 (es) |
AU (1) | AU712819B2 (es) |
CA (1) | CA2247388C (es) |
DE (1) | DE69716741T2 (es) |
DK (1) | DK0915707T3 (es) |
ES (1) | ES2185900T3 (es) |
PT (1) | PT915707E (es) |
WO (1) | WO1997026906A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4575897A (en) * | 1996-10-11 | 1998-05-11 | Universiteit Utrecht | Pharmaceutical and diagnostic use of serum amyloid p component |
US6365570B1 (en) * | 1997-10-10 | 2002-04-02 | Universiteit Utrecht | Pharmaceutical and diagnostic use of Serum Amyloid P component |
CN1301745A (zh) * | 1999-12-27 | 2001-07-04 | 上海博德基因开发有限公司 | 一种新的多肽——淀粉样糖蛋白10和编码这种多肽的多核苷酸 |
US6872541B2 (en) * | 2001-07-25 | 2005-03-29 | Coulter International Corp. | Method and compositions for analysis of pentraxin receptors as indicators of disease |
US20040091503A1 (en) * | 2002-08-20 | 2004-05-13 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
US8012472B2 (en) | 2002-12-23 | 2011-09-06 | William Marsh Rice University | Compositions and methods for suppressing fibrocytes |
US7763256B2 (en) | 2002-12-23 | 2010-07-27 | William Marsh Rice University | Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation |
US20100297074A1 (en) * | 2002-12-23 | 2010-11-25 | Richard Hans Gomer | Wound healing compositions, systems, and methods |
DK1596880T3 (da) | 2002-12-23 | 2011-06-14 | Univ Rice William M | Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering |
AU2007328206B2 (en) | 2006-12-04 | 2013-08-01 | Promedior, Inc. | Conjoint therapy for treating fibrotic diseases |
US7592695B2 (en) * | 2006-12-11 | 2009-09-22 | Graftech International Holdings Inc. | Compound heat sink |
US8497243B2 (en) | 2007-07-06 | 2013-07-30 | Promedior, Inc. | Methods and compositions useful in the treatment of mucositis |
US9884899B2 (en) | 2007-07-06 | 2018-02-06 | Promedior, Inc. | Methods for treating fibrosis using CRP antagonists |
DK2405929T3 (en) | 2009-03-11 | 2018-08-27 | Promedior Inc | SAP polypeptide for use in the treatment of autoimmune disorders and graft-versus-host disease |
PT2405928T (pt) | 2009-03-11 | 2017-02-07 | Promedior Inc | Métodos de tratamento e de diagnóstico para patologias de hipersensibilidade |
TW201103972A (en) | 2009-04-01 | 2011-02-01 | Solvay Fluor Gmbh | Process for the manufacture of etched items |
US20100266643A1 (en) * | 2009-04-01 | 2010-10-21 | Willett W Scott | Pulmonary and nasal delivery of serum amyloid p |
UA110323C2 (en) | 2009-06-04 | 2015-12-25 | Promedior Inc | Derivative of serum amyloid p and their receipt and application |
DK2987803T3 (en) | 2009-06-17 | 2018-12-17 | Promedior Inc | SAP variants and their application |
US10295539B2 (en) * | 2010-04-19 | 2019-05-21 | Meso Scale Technologies, Llc. | Serology assays |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221628A (en) * | 1991-03-19 | 1993-06-22 | Northwestern University | Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component |
US5270052A (en) * | 1991-04-19 | 1993-12-14 | New England Medical Center Hospitals, Inc. | Methods and compositions for treatment of infection by intracellular parasites |
AU662787B2 (en) * | 1991-11-27 | 1995-09-14 | Immtech International Incorporated | Method of treating viral infections |
DK17093D0 (da) * | 1993-02-15 | 1993-02-15 | Lyfjathroun H F | Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder |
AU4575897A (en) * | 1996-10-11 | 1998-05-11 | Universiteit Utrecht | Pharmaceutical and diagnostic use of serum amyloid p component |
US5908825A (en) * | 1997-01-09 | 1999-06-01 | University Of Maryland At Baltimore | Dosage composition for nasal delivery and method of use of the same |
-
1997
- 1997-01-24 AU AU14380/97A patent/AU712819B2/en not_active Ceased
- 1997-01-24 ES ES97900943T patent/ES2185900T3/es not_active Expired - Lifetime
- 1997-01-24 EP EP97900943A patent/EP0915707B1/en not_active Expired - Lifetime
- 1997-01-24 AT AT97900943T patent/ATE226829T1/de not_active IP Right Cessation
- 1997-01-24 DK DK97900943T patent/DK0915707T3/da active
- 1997-01-24 WO PCT/DK1997/000035 patent/WO1997026906A1/en active IP Right Grant
- 1997-01-24 DE DE69716741T patent/DE69716741T2/de not_active Expired - Fee Related
- 1997-01-24 CA CA002247388A patent/CA2247388C/en not_active Expired - Fee Related
- 1997-01-24 PT PT97900943T patent/PT915707E/pt unknown
-
1998
- 1998-07-24 US US09/123,883 patent/US6406698B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2247388A1 (en) | 1997-07-31 |
ATE226829T1 (de) | 2002-11-15 |
EP0915707A1 (en) | 1999-05-19 |
DE69716741T2 (de) | 2003-06-12 |
EP0915707B1 (en) | 2002-10-30 |
WO1997026906A1 (en) | 1997-07-31 |
CA2247388C (en) | 2009-06-02 |
US6406698B1 (en) | 2002-06-18 |
PT915707E (pt) | 2003-03-31 |
DE69716741D1 (de) | 2002-12-05 |
AU712819B2 (en) | 1999-11-18 |
DK0915707T3 (da) | 2003-03-03 |
AU1438097A (en) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2185900T3 (es) | Composicion farmacologica que comprende un componente p serico del amiloide para el tratamiento profilactico o terapeutico de infecciones viricas y un hit para la deteccion de union entre dicha composicion y componentes viricos. | |
WO2001068116A3 (en) | Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections | |
CO4410203A1 (es) | Formulaciones de analogos de insulina | |
YU7296A (sh) | Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
BR0011116A (pt) | Usos de uma nsaid que libera no como um sal farmaceuticamente aceitável ou um enanciÈmero do mesmo, e de uma nsaid que libera no e de um inibidor de bomba de próton suscetìvel a ácido ou um sal do mesmo ou um enanciÈmero ou de um sal do enanciÈmero, método para o tratamento de uma infecção bacteriana, e, formulação farmacêutica adequada para uso no tratamento de infecções bacterianas | |
PT933993E (pt) | Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase | |
UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
WO2001068077A3 (en) | Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections | |
ATE476984T1 (de) | Behandlung von herpes infektion mit anwendung von immunomodulatore polynukleotide sequenzen | |
BR9913157A (pt) | Processos para tratar ou previnir infecção causada por pelo menos um vìrus das flaviviridae e doenças associadas com a referida infecção e infecção causada por pelo menos um vìrus do gênero hepacivìrus da flaviviridade e doenças associadas com a referida infecção, composição farmacêutica para tratar ou previnir infecções virais, e, composto | |
HUP0002224A1 (hu) | Virusellenes hatású benzimidazol-származékok | |
UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
AR021876A1 (es) | Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado | |
BR9807673A (pt) | Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica. | |
AR030068A1 (es) | Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet | |
BR9809234A (pt) | Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo. | |
BR9916893A (pt) | Tratamento | |
NO20055512L (no) | Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider | |
EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
PE61699A1 (es) | Composicion farmaceutica de lamivudina | |
PT833903E (pt) | Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino | |
AR014082A1 (es) | Concentrado oral de sertralina | |
SE9200199D0 (sv) | Farmaceutisk komposition och dess anvaendning | |
NO20053189L (no) | HVC-kombinasjonsterapi. |